Roche Holding AG (RHHVF)
289.09
-5.79
(-1.96%)
USD |
OTCM |
Nov 14, 16:00
Roche Market Cap: 230.34B for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 14, 2024 | 230.34B |
| November 13, 2024 | 234.96B |
| November 12, 2024 | 238.53B |
| November 11, 2024 | 239.11B |
| November 08, 2024 | 238.91B |
| November 07, 2024 | 241.29B |
| November 06, 2024 | 240.79B |
| November 05, 2024 | 245.64B |
| November 04, 2024 | 249.00B |
| November 01, 2024 | 249.07B |
| October 31, 2024 | 245.49B |
| October 30, 2024 | 248.83B |
| October 29, 2024 | 251.50B |
| October 28, 2024 | 253.39B |
| October 25, 2024 | 255.65B |
| October 24, 2024 | 255.77B |
| October 23, 2024 | 255.77B |
| October 22, 2024 | 249.98B |
| October 21, 2024 | 248.49B |
| October 18, 2024 | 249.09B |
| October 17, 2024 | 249.06B |
| October 16, 2024 | 245.10B |
| October 15, 2024 | 250.99B |
| October 14, 2024 | 249.00B |
| October 11, 2024 | 248.25B |
| Date | Value |
|---|---|
| October 10, 2024 | 244.90B |
| October 09, 2024 | 248.30B |
| October 08, 2024 | 243.93B |
| October 07, 2024 | 241.61B |
| October 04, 2024 | 239.27B |
| October 03, 2024 | 244.27B |
| October 02, 2024 | 250.47B |
| October 01, 2024 | 248.95B |
| September 30, 2024 | 253.61B |
| September 27, 2024 | 256.57B |
| September 26, 2024 | 255.77B |
| September 25, 2024 | 252.72B |
| September 24, 2024 | 255.31B |
| September 23, 2024 | 249.61B |
| September 20, 2024 | 253.56B |
| September 19, 2024 | 253.10B |
| September 18, 2024 | 250.88B |
| September 17, 2024 | 252.80B |
| September 16, 2024 | 249.26B |
| September 13, 2024 | 245.74B |
| September 12, 2024 | 243.82B |
| September 11, 2024 | 251.96B |
| September 10, 2024 | 250.78B |
| September 09, 2024 | 248.54B |
| September 06, 2024 | 256.93B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
185.97B
Minimum
May 06 2024
356.53B
Maximum
Dec 29 2021
270.18B
Average
267.20B
Median
Market Cap Benchmarks
| AC Immune SA | 351.25M |
| CRISPR Therapeutics AG | 3.999B |
| Addex Therapeutics Ltd | 8.763M |
| NLS Pharmaceutics Ltd | 12.74M |
| Molecular Partners AG | 193.39M |
Market Cap Related Metrics
| PE Ratio | 19.58 |
| PS Ratio | 3.431 |
| Price to Book Value | 7.154 |
| Price to Free Cash Flow | 18.32 |
| Price | 289.09 |
| Earnings Yield | 5.11% |
| Operating PE Ratio | 14.17 |
| Normalized PE Ratio | 18.87 |